Meneldor logo

Meneldor

Europe, Gelderland, The Netherlands, Druten

Description

Meneldor is a biopharmaceutical investment company .

Investor Profile

Meneldor has made 6 investments, with 0 in the past 12 months and 83% as lead.

Stage Focus

  • Series A (67%)
  • Debt Financing (17%)
  • Seed (17%)

Country Focus

  • Norway (33%)
  • Germany (33%)
  • The Netherlands (17%)
  • United Kingdom (17%)

Industry Focus

  • Biotechnology
  • Health Care
  • Pharmaceutical
  • Health Diagnostics
  • Consulting
  • Biopharma
  • Therapeutics
  • Medical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Meneldor frequently co-invest with?

Novartis Venture Fund
Europe, Basel-Stadt, Switzerland, Basel
Co-Investments: 1
OostNL
Europe, Gelderland, The Netherlands, Apeldoorn
Co-Investments: 1
Ysios Capital
Europe, Pais Vasco, Spain, San Sebastian
Co-Investments: 1
New Enterprise Associates
North America, California, United States, Menlo Park
Co-Investments: 1
K
Europe, Oslo, Norway, Oslo
Co-Investments: 1
HTGF | High-Tech Gruenderfonds
Europe, Nordrhein-Westfalen, Germany, Bonn
Co-Investments: 2
BIF Partners
Europe, Hamburg, Germany, Hamburg
Co-Investments: 1
Lightstone Ventures
North America, California, United States, Menlo Park
Co-Investments: 1
Kistefos Venture Capital
Europe, Oslo, Norway, Oslo
Co-Investments: 1
Gilde Healthcare
Europe, Utrecht, The Netherlands, Utrecht
Co-Investments: 1

Which angels does Meneldor often collaborate with?

SP
Europe, Norway
Shared Deals: 1

What are some of recent deals done by Meneldor?

Tagworks Pharmaceuticals

Nijmegen, Gelderland, The Netherlands

Tagworks Pharmaceuticals is a privately held biotech company

BiotechnologyHealth CareMedicalPharmaceutical
Series AJun 22, 2023
Amount Raised: $65,000,000
Hemispherian

Oslo, Oslo, Norway

Hemispherian is a biotechnology firm that formulates new treatments for all kinds of cancer.

BiotechnologyConsultingHealth CareHealth Diagnostics
Series ANov 24, 2022
Amount Raised: $3,027,016
Hemispherian

Oslo, Oslo, Norway

Hemispherian is a biotechnology firm that formulates new treatments for all kinds of cancer.

BiotechnologyConsultingHealth CareHealth Diagnostics
SeedMay 3, 2022
Amount Raised: $1,330,761
Atriva Therapeutics

Tübingen, Baden-Wurttemberg, Germany

Atriva is a biopharmaceutical company which aims to develop new antiviral therapies against different respiratory viral infections.

BiopharmaBiotechnologyPharmaceuticalTherapeutics
Debt FinancingAug 12, 2020
Amount Raised: $10,143,052
Atriva Therapeutics

Tübingen, Baden-Wurttemberg, Germany

Atriva is a biopharmaceutical company which aims to develop new antiviral therapies against different respiratory viral infections.

BiopharmaBiotechnologyPharmaceuticalTherapeutics
Series AJan 3, 2019
Aptamer Group

York, York, United Kingdom

Aptamer Group develop DNA and RNA nucleic acid aptamers for use in R&D, biomarker discovery, diagnostics or therapeutic developments.

BiotechnologyHealth CareHealth Diagnostics
Series AJun 29, 2018
Amount Raised: $2,200,000